Target intelligence / Profile preview

Bacterial penicillin-binding protein 2 (PBP2)

Target
PBP2
Molecular classification
Enzyme, Transpeptidase (Class B penicillin-binding protein), Cell wall biosynthesis enzyme
01

Overview

Bacterial penicillin-binding protein 2 (PBP2) is an essential enzyme involved in the final stages of peptidoglycan synthesis within the bacterial cell wall. It catalyzes the crosslinking between glycan chains through its transpeptidase activity—a process critical for maintaining cell shape and structural integrity. PBP2 is particularly important for rod-shaped bacteria such as *Escherichia coli*, where it works with other proteins like RodA and MreB to ensure proper elongation and division. The active site contains conserved residues necessary for its enzymatic function. PBP2 serves as a primary target for β-lactam antibiotics—including ampicillin, cefaclor, cefmetazole—which bind covalently to its active site serine residue, thereby inhibiting its function and leading to bacteriolysis. Some variants exhibit unique features such as zinc ion binding that can influence stability or antibiotic susceptibility. Resistance mechanisms often involve modifications or overproduction of PBPs but do not alter their fundamental role as antibacterial targets.

Other names
PBP2Penicillin-binding protein 2
02

Mechanism of action

Inhibition of transpeptidase activity by covalent binding of β-lactam antibiotics to the active site serine, leading to disruption of peptidoglycan cross-linking and ultimately bacterial cell lysis or death

03

Biological functions

Peptidoglycan cross-linking in bacterial cell wall synthesisMaintenance of rod-shaped morphology in Gram-negative bacteriaEssential for cell elongation and division
04

Disease associations

Infection (targeted in the treatment of bacterial infections)
05

Safety considerations

No direct safety concerns related to targeting PBP2 itself; however, resistance development (e.g., via altered PBPs) is a major therapeutic challenge.
06

Interacting drugs

Ampicillin

3 more in the full profile.

07

Biomarkers

No specific biomarkers are mentioned in the provided sources. In clinical practice, resistance mutations or expression levels may serve as indirect markers.

Beyond the preview

Go deeper on Bacterial penicillin-binding protein 2 (PBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial penicillin-binding protein 2 (PBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call